TEVA), today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT06, Alvotech’s proposed biosimilar to Eylea ® (aflibercept) ...

Investors interested in arranging a meeting with the Company’s management virtually during the conference should contact the Investor Summit conference coordinator. A live webcast of the presentation ...

Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a market leader in hemp extract wellness products, is pleased to announce that the U.S. Food and Drug Administration (FDA) has ...

"Progressing to Phase 2 of an IND study with the FDA marks an important milestone in the development of our proprietary hemp genetics as regulated medicine," said Bill Morachnick, Chief Executive ...

Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex ...

Blockchain makes transformation in supply chain management offering clarity, efficiency and security. It has real-life ...

A teenage girl was able to buy weight loss jabs from Boots without her age being verified on two separate occasions, an ...

Duquesne Family Office's billionaire chief shed a trillion-dollar artificial intelligence (AI) stock in favor of a ...

Azure AI Foundry Labs will enable developers to experiment with new models and explore the latest frameworks, the company ...

At this time, I would like to welcome everyone to the Veeva Systems fiscal 2025 fourth quarter and full-year results ...

Thank you for joining us for Stereotaxis fourth-quarter and full-year 2024 earnings conference call. Certain statements during the conference call and question-and-answer period to follow may relate ...